Adverse Reactions Following Intradermal Injection of Exosome‐Based Formulations: A Case Series
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70520 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Kui Young Park. Beteiligte Einrichtung: Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Exosomes, Cosmetic Techniques, Dermal Fillers, Erythema. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Exosome‐containing formulations have recently gained popularity in aesthetic dermatology because of their regenerative and anti‐inflammatory properties. Although approved for topical use, intradermal injection of these cosmetic products remains off‐label and unregulated in many countries, including South Korea.
Aims
To describe four cases of severe cutaneous adverse reactions following the intradermal injection of unregulated exosome‐based formulations.
Methods
Four adult women developed persistent erythema, nodules, granulomatous inflammation, and scarring following intradermal administration of exosome‐containing products in a nonclinical setting. The clinical course, treatment, and outcomes of the patients were documented.
Results
All the patients experienced persistent inflammatory lesions. Treatments included corticosteroids (systemic and intralesional), laser therapy, and surgical removal. The outcomes varied, with all patients experiencing incomplete resolution and residual scarring.
Conclusion
Intradermal injection of unapproved exosome‐based formulations may cause serious and persistent cutaneous complications. This case series underscores the need for regulatory enforcement, practitioner education, and public awareness to prevent off‐label use and protect patient safety in aesthetic practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea.
ORCID-Profile: Kui Young Park
Zitieren
APA
Park, K. Y. (2025). Adverse Reactions Following Intradermal Injection of Exosome‐Based Formulations: A Case Series. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70520
Vancouver
Park KY. Adverse Reactions Following Intradermal Injection of Exosome‐Based Formulations: A Case Series. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70520
BibTeX
@article{Park2025,
author = {Park, Kui Young},
title = {Adverse Reactions Following Intradermal Injection of Exosome‐Based Formulations: A Case Series},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70520}
}
EUVIMED